WO2006066917A3 - Use of asc as a marker for colorectal cancer - Google Patents

Use of asc as a marker for colorectal cancer Download PDF

Info

Publication number
WO2006066917A3
WO2006066917A3 PCT/EP2005/013869 EP2005013869W WO2006066917A3 WO 2006066917 A3 WO2006066917 A3 WO 2006066917A3 EP 2005013869 W EP2005013869 W EP 2005013869W WO 2006066917 A3 WO2006066917 A3 WO 2006066917A3
Authority
WO
WIPO (PCT)
Prior art keywords
colorectal cancer
asc
diagnosis
marker
relates
Prior art date
Application number
PCT/EP2005/013869
Other languages
French (fr)
Other versions
WO2006066917A2 (en
Inventor
Herbert Andres
Marie-Luise Hagmann
Johann Karl
Ursula Kunert
Gabriele Pestlin
Original Assignee
Roche Diagnostics Gmbh
Hoffmann La Roche
Herbert Andres
Marie-Luise Hagmann
Johann Karl
Ursula Kunert
Gabriele Pestlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, Hoffmann La Roche, Herbert Andres, Marie-Luise Hagmann, Johann Karl, Ursula Kunert, Gabriele Pestlin filed Critical Roche Diagnostics Gmbh
Priority to EP05820046A priority Critical patent/EP1831696B1/en
Priority to JP2007544847A priority patent/JP4673895B2/en
Priority to CA2586654A priority patent/CA2586654C/en
Priority to DE602005013430T priority patent/DE602005013430D1/en
Publication of WO2006066917A2 publication Critical patent/WO2006066917A2/en
Publication of WO2006066917A3 publication Critical patent/WO2006066917A3/en
Priority to US11/820,769 priority patent/US7846653B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon

Abstract

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspase­associated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.
PCT/EP2005/013869 2004-12-23 2005-12-22 Use of asc as a marker for colorectal cancer WO2006066917A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP05820046A EP1831696B1 (en) 2004-12-23 2005-12-22 Use of asc as a marker for colorectal cancer
JP2007544847A JP4673895B2 (en) 2004-12-23 2005-12-22 Use of ASC as a marker for colorectal cancer
CA2586654A CA2586654C (en) 2004-12-23 2005-12-22 Use of asc as a marker for colorectal cancer
DE602005013430T DE602005013430D1 (en) 2004-12-23 2005-12-22 USING ASC AS A MARKER FOR COLORECTAL CARCINOMAS
US11/820,769 US7846653B2 (en) 2004-12-23 2007-06-20 ASC as a marker for colorectal cancer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04030619.3 2004-12-23
EP04030619 2004-12-23
EP05008660 2005-04-20
EP05008660.2 2005-04-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/820,769 Continuation US7846653B2 (en) 2004-12-23 2007-06-20 ASC as a marker for colorectal cancer

Publications (2)

Publication Number Publication Date
WO2006066917A2 WO2006066917A2 (en) 2006-06-29
WO2006066917A3 true WO2006066917A3 (en) 2006-08-24

Family

ID=35682429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/013869 WO2006066917A2 (en) 2004-12-23 2005-12-22 Use of asc as a marker for colorectal cancer

Country Status (8)

Country Link
US (1) US7846653B2 (en)
EP (1) EP1831696B1 (en)
JP (1) JP4673895B2 (en)
AT (1) ATE426168T1 (en)
CA (1) CA2586654C (en)
DE (1) DE602005013430D1 (en)
ES (1) ES2323429T3 (en)
WO (1) WO2006066917A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323429T3 (en) 2004-12-23 2009-07-15 F. Hoffmann-La Roche Ag USE OF ASC, AS A MARKER FOR COLORRECTAL CANCER.
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
US8685400B2 (en) 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
EP2297581B1 (en) 2008-07-03 2013-04-03 F. Hoffmann-La Roche AG Asc as a marker for lung cancer
JP6026422B2 (en) * 2010-10-20 2016-11-16 ラッシュ ユニバーシティ メディカル センターＲｕｓｈ Ｕｎｉｖｅｒｓｉｔｙ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ Lung cancer test
PT2841110T (en) * 2012-04-24 2019-05-06 Bogazici Univ A method for antigen delivery

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104593A1 (en) * 2003-05-26 2004-12-02 Roche Diagnostics Gmbh Use of protein masp as a marker for colorectal cancer
WO2005040806A2 (en) * 2003-10-15 2005-05-06 Roche Diagnostics Gmbh Use of protein asc as a marker for breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911306B1 (en) * 1999-10-18 2005-06-28 Emory University TMS1 compositions and methods of use
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
WO2004057336A2 (en) * 2002-12-20 2004-07-08 Roche Diagnostics Gmbh Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
ES2323429T3 (en) 2004-12-23 2009-07-15 F. Hoffmann-La Roche Ag USE OF ASC, AS A MARKER FOR COLORRECTAL CANCER.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104593A1 (en) * 2003-05-26 2004-12-02 Roche Diagnostics Gmbh Use of protein masp as a marker for colorectal cancer
WO2005040806A2 (en) * 2003-10-15 2005-05-06 Roche Diagnostics Gmbh Use of protein asc as a marker for breast cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE UniProt [online] 16 October 2001 (2001-10-16), "Apoptosis-associated speck-like protein containing a CARD (hASC) (PYD and CARD domain containing protein) (Target of methylation-induced silencing 1) (Caspase recruitment domain protein 5).", XP002365772, retrieved from EBI accession no. UNIPROT:Q9ULZ3 Database accession no. Q9ULZ3 *
MASUMOTO J ET AL: "ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 26 NOV 1999, vol. 274, no. 48, 26 November 1999 (1999-11-26), pages 33835 - 33838, ISSN: 0021-9258 *
YOKOYAMA T ET AL: "METHYLATION OF ASC/TMS1, A PROAPOPTOTIC GENE RESPONSIBLE FOR ACTIVATING PROCASPASE-1, IN HUMAN COLORECTAL CANCER", CANCER LETTERS, NEW YORK, NY, US, vol. 202, no. 1, 8 December 2003 (2003-12-08), pages 101 - 108, XP001206183, ISSN: 0304-3835 *

Also Published As

Publication number Publication date
EP1831696A2 (en) 2007-09-12
EP1831696B1 (en) 2009-03-18
US20090155820A1 (en) 2009-06-18
JP2008523366A (en) 2008-07-03
JP4673895B2 (en) 2011-04-20
CA2586654C (en) 2010-10-05
WO2006066917A2 (en) 2006-06-29
ES2323429T3 (en) 2009-07-15
CA2586654A1 (en) 2006-06-29
US7846653B2 (en) 2010-12-07
DE602005013430D1 (en) 2009-04-30
ATE426168T1 (en) 2009-04-15

Similar Documents

Publication Publication Date Title
KR100711046B1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2008021290A9 (en) Organ-specific proteins and methods of their use
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2007136980A3 (en) Diagnostic test media and methods for the manufacture thereof
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
WO2010136163A8 (en) Secernin-1 as a marker for cancer
DE602005025940D1 (en) METHOD FOR TESTING ENDOCRINE SUBSTANCE IN SAMPLES
EP1930445A4 (en) Kit and method for detection of urothelial cancer
FR2900936B1 (en) METHOD AND METHODS FOR DETECTING ALZHEIMER'S DISEASE
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
DE602004001994D1 (en) USE OF THE PROTEIN MASP AS A MARKER FOR COLORECTAL CARCINOMAS
WO2004071267A3 (en) Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
CA2524708A1 (en) Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer
ATE393393T1 (en) USE OF THE PROTEIN SPEE AS A MARKER FOR BREAST CANCER
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
WO2005124360A3 (en) Use of protein tebp as a marker for breast cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005820046

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2586654

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007544847

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200580044558.9

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2005820046

Country of ref document: EP